Liquadd approved for ADHD

Liquadd (dextroamphetamine sulfate, from Auriga Laboratories) oral solution 5mg/5mL has been granted FDA approval for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). It is expected to be available during the second quarter of 2008.

For more information call (877)Auriga8 or visit www.aurigalabs.com.